Literature DB >> 3422041

Cytogenetic studies in primary and metastatic neuroendocrine Merkel cell carcinoma.

G Sozzi1, M G Bertoglio, S Pilotti, F Rilke, M A Pierotti, G Della Porta.   

Abstract

Direct preparations of five primary and metastatic neuroendocrine Merkel cell carcinomas of the skin were analyzed using a G-banding technique. A recurrent structural abnormality was a rearranged chromosome #1 with involvement of p and q arms. In two cases this rearrangement appeared as a unique structural cytogenetic change. Evidence for clonal origin and karyotypic stability of this tumor was suggested by the occurrence of the same karyotypic changes in two metachronous metastases and in primary and metastatic tumor specimens of two different patients. The bands involved in rearrangements could be of significance in the molecular process of the neoplastic transformation of Merkel tumor because genes relevant to the differentiation of neural crest-derived tissue have been mapped in those regions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3422041     DOI: 10.1016/0165-4608(88)90104-5

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  Chromosome 6 trisomy as sole anomaly in a primary Merkel cell carcinoma.

Authors:  D Larsimont; A Verhest
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

2.  Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression.

Authors:  N C Dracopoli; P Harnett; S J Bale; B Z Stanger; M A Tucker; D E Housman; R F Kefford
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

3.  p73-Binding Partners and Their Functional Significance.

Authors:  Toshinori Ozaki; Natsumi Kubo; Akira Nakagawara
Journal:  Int J Proteomics       Date:  2011-01-13

4.  Two new p73 splice variants, gamma and delta, with different transcriptional activity.

Authors:  V De Laurenzi; A Costanzo; D Barcaroli; A Terrinoni; M Falco; M Annicchiarico-Petruzzelli; M Levrero; G Melino
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.